Oscillatory activity in basal ganglia and motor cortex in an awake behaving rodent model of Parkinson's disease

Basal Ganglia

Volumn 3, Issue 4, 2014, Pages 221-227

  Delaville, Claire ^a   Cruz, Ana V ^a   McCoy, Alex J ^a   Brazhnik, Elena ^a   Avila, Irene ^a   Novikov, Nikolay ^a,b   Walters, Judith R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Basal ganglia; Beta frequency oscillations; Dopamine; Motor cortex; Parkinson's disease; Substantia nigra pars reticulata

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; LEVODOPA;

ANIMAL BEHAVIOR; BASAL GANGLION; BETA RHYTHM; BRAIN FUNCTION; BRAIN REGION; CATECHOLAMINE DEPLETION; CORTICAL SYNCHRONIZATION; DOPAMINE DEPLETION; FREQUENCY MODULATION; GAMMA RHYTHM; MOTOR CORTEX; MOTOR PERFORMANCE; NERVE CELL NETWORK; NONHUMAN; OSCILLATORY POTENTIAL; PARKINSON DISEASE; PRIORITY JOURNAL; RAT MODEL; RESTING STATE NETWORK; REVIEW; SPIKE WAVE; TASK PERFORMANCE; TREADMILL EXERCISE; WAKEFULNESS; WALKING;

EID: 84897653962     PISSN: 22105336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.baga.2013.12.001     Document Type: Review

References (65)

1. Wichmann T., Delong M.R. Deep-brain stimulation for basal ganglia disorders. Basal Ganglia 2011, 1:65-77.
2. Levy R., Hutchison W.D., Lozano A.M., Dostrovsky J.O. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J Neurosci 2000, 20:7766-7775.
3. Brown P., Oliviero A., Mazzone P., Insola A., Tonali P., Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci 2001, 21:1033-1038.
4. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 2003, 18:357-363.
5. Priori A., Foffani G., Pesenti A., Tamma F., Bianchi A.M., Pellegrini M. Rhythm-specific pharmacological modulation of subthalamic activity in Parkinson's disease. Exp Neurol 2004, 189:369-379.
6. Alonso-Frech F., Zamarbide I., Alegre M., Rodriguez-Oroz M.C., Guridi J., Manrique M., et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 2006, 129:1748-1757.
7. Weinberger M., Mahant N., Hutchison W.D., Lozano A.M., Moro E., Hodaie M., et al. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol 2006, 96:3248-3256.
8. Fogelson N., Kuhn A.A., Silberstein P., Limousin P.D., Hariz M., Trottenberg T., et al. Frequency dependent effects of subthalamic nucleus stimulation in Parkinson's disease. Neurosci Lett 2005, 382:5-9.
9. Eusebio A., Brown P. Oscillatory activity in the basal ganglia. Parkinsonism Relat Disord 2007, 13(Suppl. 3):S434-S436.
10. Chen C.C., Litvak V., Gilbertson T., Kuhn A., Lu C.S., Lee S.T., et al. Excessive synchronization of basal ganglia neurons at 20Hz slows movement in Parkinson's disease. Exp Neurol 2007, 205:214-221.
11. Brown P. Abnormal oscillatory synchronisation in the motor system leads to impaired movement. Curr Opin Neurobiol 2007, 17:656-664.
12. Kühn A.A., Kupsch A., Schneider G.H., Brown P. Reduction in subthalamic 8-35Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci 2006, 23:1956-1960.
13. Brown P., Eusebio A. Paradoxes of functional neurosurgery: clues from basal ganglia recordings. Mov Disord 2008, 23:12-20.
14. Kuhn A.A., Kempf F., Brucke C., Doyle L.G., Martinez-Torres I., Pogosyan A., et al. High-frequency stimulation of the subthalamic nucleus suppresses oscillatory beta activity in patients with Parkinson's disease in parallel with improvement in motor performance. J Neurosci 2008, 28:6165-6173.
15. Kuhn A.A., Brucke C., Schneider G.H., Trottenberg T., Kivi A., Kupsch A., et al. Increased beta activity in dystonia patients after drug-induced dopamine deficiency. Exp Neurol 2008, 214:140-143.
16. Bronte-Stewart H., Barberini C., Koop M.M., Hill B.C., Henderson J.M., Wingeier B. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp Neurol 2009, 215:20-28.
17. Eusebio A., Thevathasan W., Doyle G.L., Pogosyan A., Bye E., Foltynie T., et al. Deep brain stimulation can suppress pathological synchronisation in parkinsonian patients. J Neurol Neurosurg Psychiatry 2011, 82:569-573.
18. Rosa M., Giannicola G., Servello D., Marceglia S., Pacchetti C., Porta M., et al. Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases. Neurosignals 2011, 19:151-162.
19. Eusebio A., Cagnan H., Brown P. Does suppression of oscillatory synchronisation mediate some of the therapeutic effects of DBS in patients with Parkinson's disease?. Front Integr Neurosci 2012, 6:47.
20. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968, 5:107-110.
21. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970, 24:485-493.
22. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550.
23. Sershen H., Reith M.E., Hashim A., Lajtha A. Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur J Pharmacol 1984, 102:175-178.
24. Langston J.W., Forno L.S., Rebert C.S., Irwin I. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res 1984, 292:390-394.
25. Chiueh C.C., Burns R.S., Markey S.P., Jacobowitz D.M., Kopin I.J. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci 1985, 36:213-218.
26. Langston J.W. MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 1985, 36(3):201-206.
27. Jonsson G., Sundstrom E., Mefford I., Olson L., Johnson S., Freedman R., et al. Electrophysiological and neurochemical correlates of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse. Naunyn Schmiedebergs Arch Pharmacol 1985, 331:1-6.
28. Fox S.H., Brotchie J.M. The MPTP-lesioned non-human primate models of Parkinson's disease: past, present, and future. Prog Brain Res 2010, 184:133-157.
29. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism - selective destruction of dopaminergic-nurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 1983, 80:4546-4550.
30. Avila I., Parr-Brownlie L.C., Brazhnik E., Castaneda E., Bergstrom D.A., Walters J.R. Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat. Exp Neurol 2010, 221:307-319.
31. Brazhnik E., Cruz A.V., Avila I., et al. State-dependent spike and local field synchronization between motor cortex and substantia nigra in hemiparkinsonian rats. J Neurosci 2012, 32:7869-7880.
32. Dejean C., Gross C.E., Bioulac B., Boraud T. Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. J Neurophysiol 2008, 100:385-396.
33. Dejean C., Nadjar A., Le M.C., Bioulac B., Gross C.E., Boraud T. Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats. Neurobiol Dis 2012, 46:402-413.
34. Ge S.N., Yang C., Li M., Li J., Chang X.Z., Fu J., et al. Dopamine depletion increases the power and coherence of high-voltage spindles in the globus pallidus and motor cortex of freely moving rats. Brain Res 2012, 1465:66-79.
35. Jenkinson N., Brown P. New insights into the relationship between dopamine, beta oscillations and motor function. Trends Neurosci 2011, 34:611-618.
36. Little S., Pogosyan A., Kuhn A.A., Brown P. Beta band stability over time correlates with Parkinsonian rigidity and bradykinesia. Exp Neurol 2012, 236:383-388.
37. Quiroga-Varela A., Walters J.R., Brazhnik E., Marin C., Obeso J.A. What basal ganglia changes underlie the parkinsonian state. The significance of neuronal oscillatory activity. Neurobiol Dis 2013, 58:242-248.
38. Rodriguez M., Barroso-Chinea P., Abdala P., Obeso J., Gonzalez-Hernandez T. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in Parkinson's disease. Exp Neurol 2001, 169:163-181.
39. Leblois A., Meissner W., Bioulac B., Gross C.E., Hansel D., Boraud T. Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur J Neurosci 2007, 26:1701-1713.
40. Syed E.C., Benazzouz A., Taillade M., Baufreton J., Champeaux K., Falgairolle M., et al. Oscillatory entrainment of subthalamic nucleus neurons and behavioural consequences in rodents and primates. Eur J Neurosci 2012, 36:3246-3257.
41. Stein E., Bar-Gad I. beta Oscillations in the cortico-basal ganglia loop during parkinsonism. Exp Neurol 2013, 245:52-59.
42. Tseng K.Y., Kasanetz F., Kargieman L., Riquelme L.A., Murer M.G. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 2001, 21:6430-6439.
43. Belluscio M.A., Kasanetz F., Riquelme L.A., Murer M.G. Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions. Eur J Neurosci 2003, 17:1046-1052.
44. Murer M.G., Tseng K.Y., Kasanetz F., Belluscio M., Riquelme L.A. Brain oscillations, medium spiny neurons, and dopamine. Cell Mol Neurobiol 2002, 22:611-632.
45. Walters J.R., Hu D., Itoga C.A., Parr-Brownlie L.C., Bergstrom D.A. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine. Neuroscience 2007, 144:762-776.
46. Aravamuthan B.R., Bergstrom D.A., French R.A., Taylor J.J., Parr-Brownlie L.C., Walters J.R. Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease. Exp Neurol 2008, 213:268-280.
47. Magill P.J., Bolam J.P., Bevan M.D. Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network. Neuroscience 2001, 106:313-330.
48. Valencia M., Chavez M., Artieda J., Bolam J.P., Mena-Segovia J. Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion. J Neurophysiol 2013, [Epub ahead of print] PMID:24174651.
49. Zold C.L., Kasanetz F., Pomata P.E., Belluscio M.A., Escande M.V., Galinanes G.L. Striatal gating through up states and oscillations in the basal ganglia: implications for Parkinson's disease. J Physiol Paris 2012, 106:40-46.
50. Zold C.L., Escande M.V., Pomata P.E., Riquelme L.A., Murer M.G. Striatal NMDA receptors gate cortico-pallidal synchronization in a rat model of Parkinson's disease. Neurobiol Dis 2012, 47:38-48.
51. Nambu A., Tokuno H., Takada M. Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway. Neurosci Res 2002, 43:111-117.
52. Baufreton J., Atherton J.F., Surmeier D.J., Bevan M.D. Enhancement of excitatory synaptic integration by GABAergic inhibition in the subthalamic nucleus. J Neurosci 2005, 25:8505-8517.
53. Shen K.Z., Johnson S.W. Dopamine depletion alters responses to glutamate and GABA in the rat subthalamic nucleus. Neuroreport 2005, 16:171-174.
54. Mallet N., Pogosyan A., Marton L.F., Bolam J.P., Brown P., Magill P.J. Parkinsonian beta oscillations in the external globus pallidus and their relationship with subthalamic nucleus activity. J Neurosci 2008, 28:14245-14258.
55. Holgado A.J.N., Terry J.R., Bogacz R. Conditions for the generation of beta oscillations in the subthalamic nucleus-globus pallidus network. J Neurosci 2010, 30:12340-12352.
56. Cruz A.V., Mallet N., Magill P.J., Brown P., Averbeck B.B. Effects of dopamine depletion on information flow between the subthalamic nucleus and external globus pallidus. J Neurophysiol 2011, 106:2012-2023.
57. Tachibana Y., Iwamuro H., Kita H., Takada M., Nambu A. Subthalamo-pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia. Eur J Neurosci 2011, 34:1470-1484.
58. Kannari K., Yamato H., Shen H., Tomiyama M., Suda T., Matsunaga M. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered l-DOPA in the striatum with nigrostriatal denervation. J Neurochem 2001, 76:1346-1353.
59. Brazhnik E., Hatch C.E., Novikov N., McCoy A.J., Wahba M.I., Cruz A.V., et al. Ventral medial thalamus contributes to increased high beta/low gamma coherence in the basal ganglia thalamocortical network in an awake behaving rodent model of Parkinson's disease. Soc Neurosci Abstr Online 2011, Program No. 811.23.
60. Joundi R.A., Brittain J.S., Green A.L., Aziz T.Z., Brown P., Jenkinson N. Persistent suppression of subthalamic beta-band activity during rhythmic finger tapping in Parkinson's disease. Clin Neurophysiol 2013, 124:565-573.
61. Leventhal D.K., Gage G.J., Schmidt R., Pettibone J.R., Case A.C., Berke J.D. Basal ganglia beta oscillations accompany cue utilization. Neuron 2012, 73:523-536.
62. Heimer G., Rivlin-Etzion M., Bar-Gad I., Goldberg J.A., Haber S.N., Bergman H. Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism. J Neurosci 2006, 26:8101-8114.
63. Raz A., Vaadia E., Bergman H. Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J Neurosci 2000, 20:8559-8571.
64. Wichmann T., Bergman H., Starr P.A., Subramanian T., Watts R.L., Delong M.R. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res 1999, 125:397-409.
65. Tronci E., Carta M. 5-HT1 receptor agonists for the treatment of l-DOPA-induced dyskinesia: from animal models to clinical investigation. Basal Ganglia 2013, 3:9-13.